{
    "organizations": [],
    "uuid": "26bcffb1286c7c35bcf3ef72fa6740e1240976d7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-achaogen-says-fda-to-review-plazom/brief-achaogen-says-fda-to-review-plazomicin-by-june-25-idUSFWN1R30DM",
    "ord_in_thread": 0,
    "title": "BRIEF-Achaogen Says FDA to Review Plazomicin By June 25",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 07 PM / Updated 12 minutes ago BRIEF-Achaogen Says FDA to Review Plazomicin By June 25 Reuters Staff March 21 (Reuters) - Achaogen Inc: * ACHAOGEN ANNOUNCES DATE OF FDA ADVISORY COMMITTEE MEETING FOR PLAZOMICIN * ACHAOGEN INC - ‍TARGET ACTION DATE UNDER PRESCRIPTION DRUG USER FEE ACT (PDUFA) IS JUNE 25, 2018​ * ACHAOGEN INC - ‍FDA STATED IT WAS PLANNING TO HOLD ADVISORY COMMITTEE MEETING, CO ANNOUNCED MEETING IS PLANNED FOR MAY 2 Source text for Eikon: Further company coverage:",
    "published": "2018-03-21T14:07:00.000+02:00",
    "crawled": "2018-03-21T14:29:18.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "say",
        "fda",
        "review",
        "plazomicin",
        "june",
        "reuters",
        "staff",
        "march",
        "reuters",
        "achaogen",
        "inc",
        "achaogen",
        "announces",
        "date",
        "fda",
        "advisory",
        "committee",
        "meeting",
        "plazomicin",
        "achaogen",
        "inc",
        "action",
        "date",
        "prescription",
        "drug",
        "user",
        "fee",
        "act",
        "pdufa",
        "june",
        "achaogen",
        "inc",
        "stated",
        "planning",
        "hold",
        "advisory",
        "committee",
        "meeting",
        "co",
        "announced",
        "meeting",
        "planned",
        "may",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}